Advertisement

The Rise of Effective Treatments

  • Tullio GiraldiEmail author
Chapter
  • 1.1k Downloads

Abstract

This chapter discusses the serendipitous discovery of antidepressants . While developing new antipsychotics , the treatment of a small number of patients suffering from severe endogenous depression with new experimental tricyclic derivatives provided striking results. A similar remarkable action was observed after the administration of a new antituberculosis drug, capable of inhibiting the enzyme monoamine oxidase in the brain. At the beginning these drugs received limited attention by the pharmaceutical industry but were soon developed and accepted as effective treatments of severe mood disorders . At the same time, the need appeared for clinical trials capable of objectively evaluating the efficacy and safety of new drugs, clarifying the contribution provided by the placebo effect : the randomised controlled trial became the “gold standard”, opening the way to newer and safer medicines and antidepressants

References

  1. Baumeister, A. A., Hawkins, M. F., & Uzelac, S. M. (2003). The myth of the reserpine-induced depression: Role in the historical development of the monoamine hypothesis. Journal of the History of Neurosciences, 12(2), 207–220.CrossRefGoogle Scholar
  2. Brunton, L., Lazo, J., & Parker, K. (2005). Goodman & Gilman’s, the pharmacological basis of therapeutics (11th ed.). New York: McGraw-Hill Medical.Google Scholar
  3. Carlsson, A. (1999). Birth of neuropsychopharmacology–impact on brain research. Brain Research Bulletin, 50(5–6), 363.CrossRefPubMedGoogle Scholar
  4. Carlsson, A., & Carlsson, M. L. (2006). A dopaminergic deficit hypothesis of schizophrenia: The path to discovery. Dialogues in Clinical Neurosciences, 8(1), 137–142.Google Scholar
  5. Carlton, P. L., & Monowitz, P. (1984). Dopamine and schizophrenia: An analysis of the theory. Neuroscience and Biobehavioral Reviews, 8(1), 137–151.CrossRefPubMedGoogle Scholar
  6. Castrén, E. (2005). Is mood chemistry? Nature Reviews Neurosciences, 6(3), 241–246.CrossRefGoogle Scholar
  7. Curzon, G. (1990). How reserpine and chlorpromazine act: The impact of key discoveries on the history of psychopharmacology. Trends in Pharmacological Sciences, 11(2), 61–63.CrossRefPubMedGoogle Scholar
  8. Fangmann, P., Assion, H. J., Juckel, G., et al. (2008). Half a century of antidepressant drugs: On the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. Journal of Clinical Psychopharmacology, 28(1), 1–4.PubMedGoogle Scholar
  9. Griebel, G., & Holmes, A. (2013). 50 years of hurdles and hope in anxiolytic drug discovery. Nature Reviews Drug Discovery, 12, 667–687.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Healy, D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press.Google Scholar
  11. Healy, D. (2002). The creation of psychopharmacology. Cambridge, MA: Harvard University Press.CrossRefGoogle Scholar
  12. Horwitz, A. V. (2010). How an age of anxiety became an age of depression. The Milbank Quarterly, 88(1), 112–138.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Jenkusky, M. D., & Steven, M. (1992). Public perceptions of electroconvulsive therapy: A historic review. Jefferson Journal of Psychiatry, 10(2), 3.Google Scholar
  14. Kramer, P. D. (1997). Listening to prozac: A psychiatrist explores antidepressant drugs and the remaking of the self. New York: Penguin Books.Google Scholar
  15. López-Muñoz, F., Alamo, C., Juckel, G., et al. (2007). Half a century of antidepressant drugs: On the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: Monoamine oxidase inhibitors. Journal of Clinical Psychopharmacology, 27(6), 555–559.PubMedGoogle Scholar
  16. Mitchison, M., & Davies, G. (2012). The chemotherapy of tuberculosis: Past, present and future. International Journal of Tuberculosis and Lung Diseases, 16(6), 724–732.CrossRefGoogle Scholar
  17. Moncrieff, J. (1999). An investigation into the precedents of modern drug treatment in psychiatry. History of Psychiatry, 10(40), 475–490.CrossRefPubMedGoogle Scholar
  18. Moncrieff, J. (2002, April 26). Drug treatment in modern psychiatry: The history of a delusion. In Talk given at Critical Psychiatry network conference, Beyond drugs and custody: Renewing mental health practice.Google Scholar
  19. Moncrieff, J. (2008). The creation of the concept of an antidepressant: An historical analysis. Social Science and Medicine, 66(11), 2346–2355.CrossRefPubMedGoogle Scholar
  20. Osborne, O. T. (1910). Handbook of therapy (2nd ed). The Journal of the American Medical Association. Chicago: American Medical Association.Google Scholar
  21. Preskorn, S. H. (2007). The evolution of antipsychotic drug therapy: Reserpine, chlorpromazine, and haloperidol. Journal of Psychiatric Practice, 13(4), 253–257.CrossRefPubMedGoogle Scholar
  22. Preskorn, S. H. (2010). CNS drug development: Part I: The early period of CNS drugs. Journal of Psychiatric Practice, 16(5), 334–339.CrossRefPubMedGoogle Scholar
  23. Read, J., & Bentall, R. (2010). The effectiveness of electroconvulsive therapy: A literature review. Epidemiologia e Psichiatria Sociale, 19(4), 333–347.CrossRefPubMedGoogle Scholar
  24. Roberts, R. M. (1989). Serendipity: Accidental discoveries in science. New York: Wiley.Google Scholar
  25. Roe, D. L. (1999). The discovery of dopamine psysiological importance. Brain Research Bulletin, 50(5–6), 375–376.CrossRefPubMedGoogle Scholar
  26. Shorter, E. (1997). A history of psychiatry: From the era of the asylum to the age of Prozac. New York: John Wiley.Google Scholar
  27. Shorter, E. (2011). A brief history of placebos and clinical trials in psychiatry. Canadian Journal of Psychiatry, 56(4), 193–197.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Slotkin, T. A. (1999). Mary bernheim and the discovery of monoamine oxidase. Brain Research Bulletin, 50(6), 373.CrossRefPubMedGoogle Scholar
  29. Stitzel, R. E. (1976). The biological fate of reserpine. Pharmacological Reviews, 28(3), 179–205.PubMedGoogle Scholar
  30. Tone, A. (2009). The age of anxiety: A history of America’s turbulent affair with tranquilizers. New York: Basic Books.Google Scholar
  31. Vaswani, M., Linda, F. K., & Ramesh, S. (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27(1), 85–102.CrossRefPubMedGoogle Scholar
  32. Weatherall, M. (1990). In search of a cure: A history of pharmaceutical discovery. Oxford: Oxford University Press.Google Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.University of TriesteTriesteItaly

Personalised recommendations